Literature DB >> 1519851

Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis.

R B Low1, M S Giancola, T E King, J Chapitis, P Vacek, G S Davis.   

Abstract

Collagen deposition is a prime determinant of clinical course in idiopathic pulmonary fibrosis (IPF). Identification of a marker of connective tissue metabolism would significantly enhance the ability to stage the disease and monitor the course of these patients. Prior studies of IPF have indicated that N-terminal Type III procollagen peptide (N-PIIIP) levels in blood and bronchoalveolar lavage BAL fluid are elevated. We hypothesized that elevated levels of procollagen peptides are a marker of enhanced collagen deposition, which is associated with interstitial fibrosis characterizing active disease. The purpose of the present study was to explore the relationship between N-PIIIP recovery and physiologic parameters of lung function. N-PIIIP levels in sera and bronchoalveolar lavage (BAL) from 24 patients with IPF and 29 volunteers were measured by radioimmunoassay. The extent of disease in IPF was assessed by clinical history, physical examination, chest radiograph, pulmonary physiology evaluation, and confirmatory open-lung biopsy. The severity of disease was graded using a previously described clinical, radiologic, and physiologic (CRP) scoring system. N-PIIIP normalized to albumin was higher in BAL than in serum for both volunteers (1.6-fold; p less than 0.05) and IPF patients (24-fold; p less than 0.05), consistent with local pulmonary production. BAL N-PIIIP was significantly elevated in IPF patients, whether expressed as concentration (healthy volunteer 0.11 +/- 0.06 ng/ml; IPF, 5.0 +/- 14.4; mean +/- SD; p less than 0.05) or normalized to albumin (healthy volunteer, 2.8 +/- 1.2; IPF, 73 +/- 106; p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519851     DOI: 10.1164/ajrccm/146.3.701

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension.

Authors:  Zeenat Safdar; Emilio Tamez; Wenyaw Chan; Basant Arya; Yimin Ge; Anita Deswal; Biykem Bozkurt; Adaani Frost; Mark Entman
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

2.  Evaluation of serum type III procollagen peptide as an exposure marker in retired coal workers.

Authors:  R P Schins; R J Lamers; B Préat; P J Borm
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

3.  Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation.

Authors:  Jean-Marie Forel; Christophe Guervilly; Sami Hraiech; François Voillet; Guillemette Thomas; Claude Somma; Véronique Secq; Catherine Farnarier; Marie-Josée Payan; Stéphanie-Yannis Donati; Gilles Perrin; Delphine Trousse; Stéphanie Dizier; Laurent Chiche; Karine Baumstarck; Antoine Roch; Laurent Papazian
Journal:  Intensive Care Med       Date:  2014-10-30       Impact factor: 17.440

4.  Enhanced migration of fibroblasts derived from lungs with fibrotic lesions.

Authors:  H Suganuma; A Sato; R Tamura; K Chida
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

5.  Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis.

Authors:  Richard D Fremont; Tatsuki Koyama; Carolyn S Calfee; William Wu; Lesly A Dossett; Fred R Bossert; Daphne Mitchell; Nancy Wickersham; Gordon R Bernard; Michael A Matthay; Addison K May; Lorraine B Ware
Journal:  J Trauma       Date:  2010-05

6.  Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.

Authors:  Amira Ismail Mostafa; Ayman Elsayed Salem; Heba Allah Moussa Ahmed; Aml Ibrahim Bayoumi; Radwa M Abdel Halim; Rasha M Abdel Samie
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-04-06

7.  Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease.

Authors:  Yiliang Su; Hongyan Gu; Dong Weng; Ying Zhou; Qiuhong Li; Fen Zhang; Yuan Zhang; Li Shen; Yang Hu; Huiping Li
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

8.  Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome.

Authors:  Jean-Marie Forel; Christophe Guervilly; Catherine Farnarier; Stéphane-Yannis Donati; Sami Hraiech; Nicolas Persico; Jérôme Allardet-Servent; Benjamin Coiffard; Marc Gainnier; Anderson Loundou; Aude Sylvestre; Antoine Roch; Jeremy Bourenne; Laurent Papazian
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

9.  Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort.

Authors:  Louise A Organ; Anne-Marie R Duggan; Eunice Oballa; Sarah C Taggart; Juliet K Simpson; Arthur R Kang'ombe; Rebecca Braybrooke; Philip L Molyneaux; Bernard North; Yakshitha Karkera; Diana J Leeming; Morten A Karsdal; Carmel B Nanthakumar; William A Fahy; Richard P Marshall; R Gisli Jenkins; Toby M Maher
Journal:  Respir Res       Date:  2019-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.